US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 20.760
  • +0.740+3.70%
Close Apr 26 16:00 ET
  • 20.800
  • +0.040+0.19%
Post 18:11 ET
2.00BMarket Cap-3830P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday+0.41%